- Julian Lloyd Webber says his prostate cancer treatment was successful.
- The 75-year-old cellist is preparing to return to touring in Ireland.
- He highlights the role of PSA blood tests in his own diagnosis.
Julian Lloyd Webber announces successful prostate cancer treatment
Cellist Julian Lloyd Webber has announced that his treatment for prostate cancer was successful. The 75-year-old British musician said he feels “very grateful” for the expert care he received and is now looking forward to returning to touring in Ireland.
In a statement reported by Yahoo News UK, Lloyd Webber said: “I feel very grateful and now, after my successful treatment, I can’t wait to start my Irish tour next week.”
The news marks a hopeful new chapter for a musician who has already overcome a long, injury-related absence from the concert platform before his cancer diagnosis earlier this year. For readers interested in how cellists continue to bring the instrument to new audiences, our report on Gautier Capuçon’s performance of Massenet’s Thaïs – Méditation offers another recent view of the cello’s expressive voice in the concert hall and online.
Diagnosis revealed after a long-awaited return to the stage
Lloyd Webber revealed his diagnosis in April, shortly after celebrating his 75th birthday and returning to live performance at a charity gala at London’s Wigmore Hall. He had kept the diagnosis private until after the concert because he did not want to disappoint those involved, before explaining that treatment needed to begin promptly.
At the time, he said he was encouraged by his medical team’s expectations and hoped to make a full recovery. He also said that he did not intend to cancel his professional engagements. Contemporary reporting by The Independent confirmed both the diagnosis and the significance of the Wigmore Hall appearance.
The concert represented more than a birthday celebration. It was Lloyd Webber’s return to the platform after a 12-year absence from live performance, caused by a herniated disc that affected his ability to use the bowing arm. The injury became so severe that he sold the Stradivarius cello he had played, believing at one point that he might never return to public performance.
A gradual, disciplined return to playing
His road back to the cello was gradual. Before the Wigmore Hall event, Lloyd Webber described rebuilding his playing in small stages: scales first, then brief practice sessions, then longer stretches as strength and confidence returned. That process will be familiar to musicians recovering from injury, who know that a return to sound is rarely achieved in a single leap.
For a cellist of Lloyd Webber’s generation and stature, the return carried particular resonance. His recording of Elgar’s Cello Concerto won a Brit Award, and his career has included performances at major venues and a celebrated appearance at the closing ceremony of the London 2012 Olympic Games. He was appointed OBE in 2021 for services to music.
His story also sits within a wider family of British musical life. He is the younger brother of composer Andrew Lloyd Webber, but Julian Lloyd Webber built a distinctive musical identity of his own: one associated with a warm, direct sound, an extensive recording catalogue and a long commitment to music education.
PSA testing and a public message
Alongside his treatment update, Lloyd Webber said that he had been shocked to learn of possible changes affecting access to PSA blood tests. He said that a blood test had enabled his own cancer to be discovered.
A PSA test measures the amount of prostate-specific antigen in a blood sample. A raised PSA level can be associated with prostate cancer, but it can also have other causes. The NHS information on prostate cancer diagnosis explains that PSA testing is not a universal screening programme, but people with a prostate can discuss symptoms, risk and testing with a GP.
Lloyd Webber’s comments should not be read as personal medical advice. Decisions about testing, diagnosis and treatment require individual discussion with qualified healthcare professionals. His experience does, however, add a public voice to a subject that can be difficult to talk about, particularly when early investigation may make a meaningful difference.
Looking ahead: Irish tour and beyond
Following the successful treatment, Lloyd Webber said he was looking forward to his upcoming Irish dates. This is an especially encouraging prospect after the sequence of challenges that preceded them: a lengthy injury-related absence, the carefully managed return to the stage, a cancer diagnosis and treatment.
His renewed plans are a reminder that a musical life is not measured only by uninterrupted activity. It can also be measured by resilience, patience and the willingness to return to an instrument after circumstances have changed. For younger musicians at the beginning of their own journeys, the archival film of seven-year-old Yo-Yo Ma playing for President Kennedy offers a striking counterpart: another cellist, at the opposite end of a long career, showing why the chance to make music matters at every stage of life.
A continuing voice in British music
Julian Lloyd Webber’s statement is, above all, good news from a much-loved figure in British classical music. His career has encouraged generations of listeners to hear the cello as an instrument of intimacy, colour and direct communication. The prospect of hearing him again in concert will be warmly welcomed by audiences, colleagues and students alike.
As he prepares to return to touring, the most fitting response is to take his words at face value: gratitude for expert care, relief that treatment was successful and anticipation of music still to come.
